药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Gamolenic acid
The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Gamolenic acid.
Potassium cation
Phenothiazine
The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Phenothiazine.
Potassium cation
Evening primrose oil
The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Evening primrose oil.
Potassium cation
Borage oil
The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Borage oil.
Potassium cation
Sage oil
The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Sage oil.
Potassium cation
Sodium phosphate, monobasic
The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Sodium phosphate, monobasic.
Potassium cation
Levopropoxyphene
The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Levopropoxyphene.
Potassium cation
Deacetoxycephalosporin C
The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Deacetoxycephalosporin C.
Potassium cation
Cephalosporin C
The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Cephalosporin C.
Potassium cation
Cephalosporin analog
The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Cephalosporin analog.
Potassium cation
Imipenem
The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Imipenem.
Potassium cation
Valproate bismuth
The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Valproate bismuth.
Potassium cation
Gepefrine
The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Gepefrine.
Potassium cation
Methoxyphenamine
The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Methoxyphenamine.
Potassium cation
Mephedrone
The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Mephedrone.
Potassium cation
Ritobegron
The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Ritobegron.
Potassium cation
Iofetamine I-123
The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Iofetamine I-123.
Potassium cation
Eluxadoline
The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Eluxadoline.
Potassium cation
Methylthioninium
The risk or severity of serotonin syndrome can be increased when Methylthioninium is combined with Cannabidiol.
Potassium cation
Chlorphentermine
The risk or severity of serotonin syndrome can be increased when Chlorphentermine is combined with Cannabidiol.